(Q84588841)
Statements
Suppressive activity rather than frequency of FoxP3(+) regulatory T cells is essential for CA-125-specific T-cell activation after abagovomab treatment (English)
Silke Reinartz
Jacobus Pfisterer
Andreas du Bois
Christian Jackisch
Klaus H Baumann